Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia

• Authors: Hope Mumme, Emory University; Sunil Raikar, Emory University; Swati Sharma Bhasin, Emory University; Beena/Elizabeth Thomas, Emory University; taylor Lawrence, Children's Healthcare of Atlanta; Elizabeth P. Weinzierl, Children's Healthcare of Atlanta; Yakun Pang, Stanford University; Deborah DeRyckere, Emory University; Chuck Gawad, Stanford University; Dan Wechsler, Emory University; Christopher Porter, Emory University; Sharon M. Castellino, Emory University; Douglas K. Graham, Emory University; Manoj Bhasin, Emory University
• Journal Title: Genome Medicine
• Volume: Volume 15
• Publisher: Springer Nature | 2023-10-16, Pages 83-None
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1186/s13073-023-01241-z
• Subjects: Health Sciences, Oncology; Biology, Cell
• Keywords: Mixed phenotype acute leukemia; Single-cell RNA sequencing; Tumor microenvironment

Abstract

Background Mixed phenotype acute leukemia (MPAL), a rare subgroup of leukemia characterized by blast cells with myeloid and lymphoid lineage features, is difficult to diagnose and treat. A better characterization of MPAL is essential to understand the subtype heterogeneity and how it compares with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Therefore, we performed single-cell RNA sequencing (scRNAseq) on pediatric MPAL bone marrow (BM) samples to develop a granular map of the MPAL blasts and microenvironment landscape. Methods We analyzed over 40,000 cells from nine pediatric MPAL BM samples to generate a single-cell transcriptomic landscape of B/myeloid (B/My) and T/myeloid (T/My) MPAL. Cells were clustered using unsupervised single-cell methods, and malignant blast and immune clusters were annotated. Differential expression analysis was performed to identify B/My and T/My MPAL blast-specific signatures by comparing transcriptome profiles of MPAL with normal BM, AML, and ALL. Gene set enrichment analysis (GSEA) was performed, and significantly enriched pathways were compared in MPAL subtypes. Results B/My and T/My MPAL blasts displayed distinct blast signatures. Transcriptomic analysis revealed that B/My MPAL profile overlaps with B-ALL and AML samples. Similarly, T/My MPAL exhibited overlap with T-ALL and AML samples. Genes overexpressed in both MPAL subtypes’ blast cells compared to AML, ALL, and healthy BM included MAP2K2 and CD81. Subtype-specific genes included HBEGF for B/My and PTEN for T/My. These marker sets segregated bulk RNA-seq AML, ALL, and MPAL samples based on expression profiles. Analysis comparing T/My MPAL to ETP, near-ETP, and non-ETP T-ALL, showed that T/My MPAL had greater overlap with ETP-ALL cases. Comparisons among MPAL subtypes between adult and pediatric samples showed analogous transcriptomic landscapes of corresponding subtypes. Transcriptomic differences were observed in the MPAL samples based on response to induction chemotherapy, including selective upregulation of the IL-16 pathway in relapsed samples. Conclusions We have for the first time described the single-cell transcriptomic landscape of pediatric MPAL and demonstrated that B/My and T/My MPAL have distinct scRNAseq profiles from each other, AML, and ALL. Differences in transcriptomic profiles were seen based on response to therapy, but larger studies will be needed to validate these findings.